Analyst Profile

Followed by 11 followers
.
Michael Ryskin

Michael Ryskin

Bank of America Securities
Wall Street Analyst
#2,915 out of 8,142 Wall Street Analysts
#6,611 out of 24,385 experts

Success Rate

52%
22 out of 42 transactions made a profit

Average Return

+5.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Michael Ryskin's trades since 2017 and holding each position for 1 Year would result in 52.38% of your transactions generating a profit, with an average return of 5.3% per rating.

Stock Rating Distribution

57Ratings
54.39% Buy
24.56% Hold
21.05% Sell
Distribution of Michael Ryskin's ratings

Additional Information

Main Sector:General
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Smiledirectclub Inc
(SDC)
Rating:Sell
Date:Nov 09, 2021 - Nov 09, 2022
Return:+85.80%
The most profitable rating made by Michael Ryskin

Michael Ryskin's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Exact Sciences
Jul 26, 2017
Buy
Reiterated
$40.00
(-13.72% Downside)
1Ratings
100%
+56.10%
Phibro Animal Health
Aug 29, 2019
Sell
Reiterated
$18.00
(44.69% Upside)
1Ratings
0%
-4.20%
Elanco Animal Health
Nov 09, 2020
Buy
Reiterated
$35.00
(165.15% Upside)
6Ratings
80%
+21.68%
AbSci
Nov 10, 2021
Sell
Downgraded
$10.00
(277.36% Upside)
2Ratings
100%
+76.20%
Schrodinger
Nov 11, 2021
Hold
Downgraded
$52.00
(199.71% Upside)
4Ratings
0%
-33.20%
Recursion Pharmaceuticals
Apr 18, 2022
Hold
Downgraded
$10.00
(7.41% Upside)
2Ratings
0%
-71.10%
Idexx Laboratories
May 05, 2022
Hold
Downgraded
$470.00
(7.97% Upside)
6Ratings
60%
+5.26%
Singular Genomics Systems
Aug 10, 2022
Sell
Downgraded
$3.00
(47.06% Upside)
4Ratings
33%
-11.17%
Exscientia Plc
Aug 23, 2022
Buy
Reiterated
$16.00
(160.59% Upside)
2Ratings
0%
-54.20%
Align Tech
Oct 17, 2022
Sell
Reiterated
$200.00
(0.80% Upside)
6Ratings
60%
-2.46%
List of latest recommendations made by Michael Ryskin. Click to expand and see Michael Ryskin's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >